Market Overview

UPDATE: Cantor Fitzgerald Reiterates Buy Rating, Raises PT on CVS Caremark Corporation

Related CVS
Top 4 Stocks In The Health Care Plans Industry With The Highest Revenue
Retail ETFs Hitting Highs Ahead Of Holidays
Making Money With Charles Payne: 11/24/14 (Fox Business)

In a report published Friday, Cantor Fitzgerald reiterated its Buy rating on CVS Caremark Corporation (NYSE: CVS), and raised its price target from $55.00 to $57.00.

Cantor Fitzgerald noted, “Despite some concerns over what CVS could possibly do for an encore following some exceptional tailwinds in 2012, the combination of a major dividend increase and very strong (above consensus) EPS guidance set the tone for a very upbeat analyst meeting. We liked what we heard in the management presentations and have greater conviction in our 2013 earnings outlook. We reiterate our BUY rating with a revised price target is $57 (from $55).”

CVS Caremark Corporation closed on Thursday at $48.50.

Latest Ratings for CVS

DateFirmActionFromTo
Nov 2014Deutsche BankMaintainsHold
Nov 2014FBR CapitalMaintainsOutperform
Sep 2014Cowen & CompanyUpgradesMarket PerformOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Price Target Analyst Ratings

 

Related Articles (CVS)

Around the Web, We're Loving...

Get Benzinga's Newsletters